RMD

#320
ResMed Inc.
256.2100
+0.30%
Sector:
Base:
Profit Currency:
Daily Range
254.3400
256.4100
Year Range
237.6250
277.6700
Daily Change
+0.30%
Monthly Change
+0.40%
6 month change
-1.08%
Year Change
-1.08%
Previous Close
255.4500
Open
255.3350
Bid
Ask
Low
254.3400
High
256.4100
Volume
1 241
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 37.3662 B
  • Employee 11 K
  • Founded N/A
  • CEO Michael J. Farrell
  • Website www.resmed.com
  • Headquarter Delaware, United States
  • FIGI BBG000L4M7F1
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
23.82
Price to sales ratio
6.56
Dividends per share
1.2
Dividend yield %
2.29

ResMed Inc

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.

News